US drugmaker Eli Lilly and Company announced that it was slashing prices of its most commonly-prescribed insulins by 70 percent. Lilly said it would cut the price of its non-branded insulin to $25 a vial from May 1. It will also cut the price of Humalog, the company’s most commonly-prescribed insulin and Humalin injections by 70 percent towards the end of the year.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Pfizer causes Myocarditis in children

On Dec 17: The U.S. Centers for Disease Control and Prevention told…

India records 10,000 new Covid-19 cases in a day

India reported more than 10,000 new cases of Covid-19 in a day,…

Coronavirus Survives on Surfaces for 28 Days: Study

ANKARA, Oct 12 (AA/APP): The novel coronavirus survives on surfaces for 28…